PJP News Alert Dynamic Pharmaceuticals Powershares (PJP) 73.81

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 1:35 AM

Dynamic Pharmaceuticals Powershares (PJP) 73.81 $PJP

Pharma And Biotech Funds Add Zest To Your Portfolio
John Dowdee - at Seeking Alpha - Fri Feb 13, 7:10AM CST

PBE: 52.78 (+0.30), HQL: 27.40 (+0.16), FBT: 110.21 (+1.02), PJP: 73.81 (+0.69), XBI: 203.40 (+1.36), XPH: 118.58 (+0.98), IBB: 323.46 (+3.04), HQH: 34.20 (+0.06)

Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 05, 10:00AM CST
How pharma ETFs are looking after the string of earnings beat and disappointing guidance?
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), PFE: 34.64 (-0.23), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)

Can Pharma ETFs Continue Their Uptrend In 2015?
Zacks Funds - Seeking Alpha - Fri Jan 09, 4:37PM CST
The pharmaceutical sector, which had been witnessing several tax inversion deals over the last few months, is not likely to go down this route given the Sep 2014 notice issued by the U.S. Department of the Treasury. New rules imposed by the Treasury...
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)

Can Pharma ETFs Continue their Uptrend in 2015? - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jan 09, 11:00AM CST
Several factors suggest that Pharma ETFs may continue their strong performance this year as well.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)

After Yesterday's Decline of 1.38%, Powershares Dynamic Pharmaceuticals Portfolio Offers Investors Better Value
Comtex SmarTrend(R) - Wed Dec 24, 4:54PM CST
Powershares Dynamic Pharmaceuticals Portfolio (AMEX

JP) traded in a range yesterday that spanned from a low of $65.45 to a high of $66.75. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $66.95 on volume of 181,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PJP: 73.81 (+0.69)

Bulls Rule As Volatility Recedes And Investors Position For Holiday Cheer
Scott Martindale - Seeking Alpha - Mon Nov 10, 9:10AM CST
After displaying a classic V-bottom reversal to what turned out to be a quick and anemic attempt by the bears to bring about a real correction, bullish fervor is becoming contagious, especially as the traditionally strong holiday season approaches....
ACT: 285.37 (+3.71), LUV: 43.30 (-0.20), IYZ: 30.91 (+0.12), SPY: 209.78 (+0.86), IDU: 113.30 (-1.71), AMAT: 24.12 (-0.02), JAZZ: 169.69 (+6.89), IYW: 107.68 (+0.94), FDX: 176.47 (+0.17), IYK: 106.66 (-0.09), IYJ: 109.15 (+0.67), XTN: 106.48 (+0.70), IYH: 149.63 (+0.84), LSTR: 68.62 (-0.05), SWKS: 81.85 (-0.57), IYM: 86.13 (+0.83), IYC: 142.85 (+0.77), NXPI: 84.79 (-0.60), SOXX: 95.43 (+0.67), IYF: 90.01 (-0.04), IYE: 46.47 (+0.95), ADM: 48.10 (+0.66), ARRS: 26.68 (+0.41), PJP: 73.81 (+0.69), ALXN: 182.29 (+6.02)

Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 1:00PM CDT
Pharma ETFs have been surging over the past one week buoyed by solid earnings from big industry players.
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)

New 52-Week Highs: Which Stock ETFs Are Shining The Brightest?
Gary Gordon - Seeking Alpha - Fri Oct 24, 11:15AM CDT
In spite of a stock market sell-off that nearly set the S&P 500 back 10%, some stock ETFs have already recovered. That's right. A handful of funds barely trembled during last week's frightful liquidation. Shortly thereafter, this intrepid group...
PJP: 73.81 (+0.69), SPHD: 33.19 (-0.15), VPU: 98.07 (-1.43), RHS: 107.77 (-0.29), USMV: 41.48 (+0.03)

True Fund Costs: Health Care Sector
David Trainer - Seeking Alpha - Tue Oct 21, 8:30AM CDT
This report focuses on providing investors the true costs incurred when investing in Health Care ETFs and mutual funds. A key component of our fund ratings, Total Annual Cost (TAC) accounts for all the costs borne by investors, including...
RXL: 131.80 (+1.10), PJP: 73.81 (+0.69), BIB: 141.30 (+2.39), PTH: 56.26 (+0.35), FXH: 62.97 (+0.34)

Healthcare ETFs for your Portfolio's Wellness - ETF News And Commentary
Neena Mishra - ZACKS - Fri Sep 26, 10:56AM CDT
Healthcare sector has been beating the broader market and looks well poised to continue its outperformance in the longer term.
PJP: 73.81 (+0.69), VHT: 130.56 (+0.66), XLV: 70.72 (+0.28)

Pharma ETF Investing 101 - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:00AM CDT
Rising demand from emerging markets and new products will continue to drive growth in the pharma industry.
IHE: 163.48 (+1.38), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)

Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 31, 9:01AM CDT
Following solid results from Amgen, among others, these biotech ETFs could be ones to watch.
GILD: 101.90 (+1.10), PJP: 73.81 (+0.69), AMGN: 153.48 (+0.30), IBB: 323.46 (+3.04), BBH: 122.45 (+0.86), CELG: 115.88 (+0.16)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nomada Fund Launches: A Game-Changer in New Media

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Chicago Scenic Studios’ Equipment Up for Grabs in Auction

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

TomoIQ Unveils Money Finder at Money20/20 Event

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Ama La Vida's New Coaching: More Than a Financial Plan

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...